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  ABSTRACT
Background: Donor safety is the first priority in living donor liver transplantation (LDLT).
Objective: To determine the characteristics and outcome of live liver donors who underwent donor hepatec-
tomy from January, 1997 to May, 2007 at Massachusetts General Hospital.
Methods: 30 patients underwent LDLT between January, 1997 and May, 2007 at our institution.
Results: The type of graft was the right lobe (segments 5-8) in 14, left lobe (segments 2-4) in 4, and left lat-
eral sector (segments 2 and 3) in 12 patients. The mean donor age was 36 (range: 26-57) years. The mean 
follow-up was 48 (range: 18-120) months. No deaths occurred. Overall, 8 (26.6%) patients experienced a 
total of 14 post-operative complications. Donor complications based on graft type were as follows: left lat-
eral sector (16.7%), left lobe (25%), and right lobe (35.7%). The experience was divided into two periods 
1997-2001 (n=15) and 2002-2007 (n=15). Overall complications during 2 periods were 40% and 13.3%, 
respectively (p<0.001). The incidence of grade III complication also significantly decreased; 66.7% vs 33.3% 
(p<0.01).
Conclusion: Partial hepatectomy in living donors has a learning curve which appears to be approximately 15 
cases. This learning curve is not restricted to the surgeons performing the procedure but involves all aspects 
of patient care.
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INTRODUCTION
L
iver transplantation is the treatment of 
choice for patients with end-stage liver 
disease (ESLD). Efforts to increase de-
ceased liver donation have seen only modest 
successes. Rising rates of death on the wait-
ing list led to the use of more innovative and 
risky approaches to transplantation, including 
reduced size and split liver organs and, more 
recently, living donors [1].
Living  donor  liver  transplantation  (LDLT) 
has emerged successfully to partially relieve 
the shortage of deceased donor grafts caused 
by  the  increasing  demands  of  patients  with 
ESLD.  Despite  rapid  adoption  of  LDLT  by 
numerous centers, many controversies on do-
nor selection, indications, techniques, and eth-
ics  exist  [1,2].  Before  the  widely  publicized 
death in New York City, there were only anec-
dotal reports about deaths or the need for liver 
transplantation following the donor procedure 
[1-4]. The Vancouver meeting then reported 
14 deaths worldwide in approximately 7000 
LDLT procedures [5]. Although potentially 
lifesaving for the recipient, LDLT is a unique 
surgical procedure that subjects a healthy do-
nor to a major surgical procedure without di-
rect therapeutic benefits. We conducted this 
study to determine the characteristics and out-
come of live liver donors who underwent do- Int J Org Transplant Med 2010; Vol. 1 (3)    www.ijotm.com 
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nor hepatectomy from January, 1997 to May, 
2007 at Massachusetts General Hospital.
PATIENTS AND METHODS
All potential donors were evaluated in three 
phases.  Phase  1  comprised  a  comprehensive 
history,  physical  examination  and  laborato-
ry profile, which includes viral serology and 
blood type. In phase 2, potential donors were 
counseled by a nontransplant physician, acting 
as a donor advocate, who ensured donor com-
mitment, motivation and understanding of the 
risks involved. A social worker and financial 
advisor also helped the donor with social or 
financial issues that may arise during the pro-
cess of donation. Finally, in phase 3 the donor 
underwent CT volumetric study and magnet-
ic resonance cholangiography (MRC) or CT 
cholangiography.
Data were collected on all 30 live liver do-
nors who underwent donor hepatectomy from 
January, 1997 to May, 2007 at Massachusetts 
General Hospital.
Table 1: Donor characteristics
Mean age (range) 36 (26-57)
Sex 
   Male 24
   Female  6
Mean BMI (kg/m2)  26
Relatedness to recipient
   Biologically related
       Father 8
       Mother 6
       Son 5
       Brother 3
       Uncle 1
      Aunt 1
   Not biologically related
       Brother-in-law 1
       Spouse 2
       Friend 3
Table 2: Graft characteristics and outcomes
Mean graft weight in gram (range)
   LLS  (n=12) 287 (247-350)
   LL (n=4) 415 (385-450)
   RL (n=14) 838 (621-1100)
Mean EBL in mL (range)
   LLS 391 (300-600)
   LL 525 (450-600)
   RL 566 (300-1000)
Mean LOS in day (range)
   LLS 8 (6-12)
   LL 7.2 (5-10)
   RL 7.7 (5-11)
Complications ileus (n=1), biloma (n=1)
atelectasis (n=1)
atelestasis (n=2), phelebitis (n=1), GI bleeding (n=1), biloma (n=1), 
wound dehiscence (n=1), biliary stricture (n=1), perihepatic fluid 
collection (n=1), pleural effusion (n=1), peripancreatic fluid 
collection (n=1), ventral hernia (n=1)
   LLS (n=2)
   LL (n=1)
   RL (n=5)
Number of complications
   0 22
   1 5
   2 1
   3 1
   4 1
Readmission
   0 25
   1 3
   2 1
   3 1
LLS: Left lateral sector, LL: Left lobe, RL: Right lobe, LOS: Length of stay, EBL: Estimated blood loss www.ijotm.com    Int J Org Transplant Med 2010; Vol. 1 (3) 
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During this period, our program evolved to 
improve outcome after live donor hepatecto-
my. These changes were in all aspects of do-
nor work-up and management. For example, 
routine  mesenteric  angiogram  was  replaced 
by CT angiography. In one case, donor hepa-
tectomy was aborted as MRC missed a seg-
ment  IV  bile  duct  which  was  draining  into 
the right system. This was identified during 
intra-operative cholangiogram and the donor 
right hepatectomy was aborted. Since then, we 
have replaced MRC with CT cholangiography. 
Other examples are routine application of low 
central venous pressure during the parenchy-
mal transaction, epidural pain management, 
early  post-operative  mobilization  and  oral 
diet advancement, aggressive management of 
phosphorus  repletion  and  respiratory  toilet. 
A percutaneous liver biopsy was not routine-
ly performed before dissection of the hepatic 
hilum. For operative safety, one or two units 
of autologous packed red cells were stored be-
fore the operation. Operation was planned to 
guarantee 30%–35% remnant liver volume in 
the donor. The middle hepatic vein was never 
taken in right lobe donation.
Standard surgical techniques for LDLT have 
been previously described [6-9]. All donors 
underwent  intra-operative  cholangiography 
through the cystic duct at the beginning of 
the procedure. We used Cavitron Ultrasonic 
Surgical Aspirator (CUSA) and bipolar elec-
trocautery for parenchymal transaction.
For assessing complications, the uniform re-
porting of adverse outcomes of surgery pro-
posed by Clavien, et al [10], was adopted as 
followed: grade I, deviation from the normal 
post-operative  course  but  without  the  need 
for therapy; grade II, complication requiring 
pharmacologic treatment; grade III, compli-
cation with the need for surgical, endoscopic 
or radiological intervention (IIIa/b: without/
with the need for general anesthesia); grade 
IV,  life-threatening  complication  requiring 
intensive care; and grade V, death. Original-
ly developed for general surgical procedures, 
this system has been widely adopted in liver 
transplantation for standardization of report-
ing of complication rates for both donors and 
recipients.
Values are given as mean and range unless 
otherwise stated. Student’s t test was used to 
compare means. A p value <0.05 was consid-
ered statistically significant.
RESULTS
Donor characteristics are shown in Table 1. 
The mean donor age was 36 (range: 26-57) 
years. Eighty percent of donors were biologi-
cally related to the recipients. No mortality 
occurred. The type of allograft was the right 
lobe  (segments  5-8  without  middle  hepatic 
vein) in 14, left lobe (segments 2-4) in four, 
and left lateral sector (segments 2 and 3) in 12 
patients (Table 2).
Overall, 8 (26.6%) patients experienced a total 
of 14 post-operative complications. The mean 
length of hospitalization (LOS) was 7.5 (range: 
5-12) days. Table 2 shows LOS based on the 
graft type.
Donor complications based on graft type were 
as follows: left lateral sector (16.7%), left lobe 
Table 3: Donor complication and the Clavien’s classification
Grade of Complications: n(%) Complications (1997-2001)(n) Complications (2002-2007) 
I: 4 (28.6%) atelectasis (3) superficial phlebitis (1)
II: 1 (7.1%) Ileus (1) 0
IIIa: 7 (50%)
Biloma (2), perihepatic fluid 
collection (1), GI bleeding (1), 
biliary stricture (1)
peripancreatic fluid collection (1), 
pleural effusion (1)
IIIb: 2 (14.3%) wound dehiscence (1)  ventral hernia (1)
IV: 0 0 0
V: 0 0 0 Int J Org Transplant Med 2010; Vol. 1 (3)    www.ijotm.com 
(25%), and right lobe (35.7%). Type and grade 
of complications are summarized in Tables 2 
and 3. The most common complications were 
respiratory (13%; 3 atelectasis and one pleural 
effusion which needed drainage) and biliary 
(10%). All donors with atelectasis responded 
to aggressive chest physiotherapy. There were 
three biliary complication; two bilomas which 
responded  to  percutaneous  drain  placement 
and  one  biliary  stricture  which  needed  two 
sessions of endoscopic management and stent 
placement.
The experience was divided into two periods 
1997–2001  (n=15)  and  2002–2007  (n=15). 
Overall complications (Tables 3 and 4) dur-
ing the two periods were 6/15 (40%) and 2/15 
(13%), respectively (p<0.001). The incidence of 
grade III complication also decreased signifi-
cantly; 67% vs 33% (p<0.01). The total number 
of complications also dropped from 10 (71%) in 
the first period to four (29%) in the second pe-
riod. The number of readmissions also signifi-
cantly dropped (40% vs 13%). Interestingly, the 
majority of allografts in the first period were 
left lateral segment (10/15) which changed to 
right lobe (10/15) in the second period. Despite 
of this fact, the LOS did not change signifi-
cantly (8.2 vs 7.4 days).
DISCUSSION
LDLT has been controversial since its incep-
tion. Begun in response to deceased donor or-
gan shortage and waiting list mortality, LDLT 
was initiated in 1989 in children, grew rapidly 
after its first general application in adults in 
the United States in 1998, and has declined 
since 2002 [1,2]. LDLT still accounts for less 
than 5% of adult liver transplants, significant-
ly less than in kidney transplantation where 
living donors account for 40% of all trans-
plantations performed [1]. The ethics, optimal 
utility, and application of LDLT remain to be 
defined. In addition, most studies to date have 
focused on post-transplantation outcomes and 
have not included the effect of the learning 
curve on outcome. The initial reports of high 
recipient successes and low donor morbidity 
rate led to rapid expansion of adult-to-adult 
LDLT, and, by 2001, this procedure accounted 
for more that 400 transplantations (10% of all 
adult liver transplantations done in the Unit-
ed States that year) [1]. However, following a 
well-publicized donor death in 2002, rates of 
adult-to-adult  LDLT  declined  precipitously 
and have remained in the range of 250–300 
per year subsequently [1,2].
The  Adult-to-Adult  Living  Donor  Liver 
Transplantation  (A2ALL)  cohort  study  was 
initiated  in  2002  as  a  cooperative  research 
agreement funded by the National Institute of 
Health with nine liver transplant centers and 
a  data  coordinating  center.  Across  the  nine 
A2ALL centers, the overall donor complica-
tion rate was 38% [11]. In A2ALL study, the 
majority of donors (n=245; 62%) did not suf-
fer any complications, defined by the Clavien 
classification as any alteration from the ideal 
post-operative course with complete recovery. 
However, 148 (38%) donors had a total of 220 
complications.  Eighty-two  (21%)  donors  had 
one complication, 40 (10%) had two, 16 (4%) 
had three, and 10 (3%) had four to seven com-
plications.  In  our  study,  eight  (27%)  donors 
had a total of 14 complications; five (63%) had 
one complication, one (13%) had two, one (13%) 
had three and another one (13%) had four com-
Table 4: Outcomes in two different periods
First 15 cases (1997-2001) Second 15 cases (2002-2007)
Donors with complications (n=8) 6/15 (40%) 2/15  (13.3%)*
Total complications (n=14) 10 (71.4%) 4 (28.6%)*
Grade III complication (n=9)  6 (66.7%) 3 (33.3%)*
Readmission 6/15 (40%) 2/15  (13.3%)*
LOS (day) 8.2 7.4
LOS: Length of stay, * p<0.05
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plications.
In  A2ALL  cohort  [11],  the  most  common 
complication in donors were biliary (9%), bac-
terial infections (12%), incisional hernia (6%), 
pleural  effusion  requiring  intervention  (5%), 
neuropraxia (4%), re-exploration (3%), wound 
infections (3%), and intra-abdominal abscess 
(2%).  Certain  individual  complications  are 
worth highlighting: Biliary complications have 
been one of the major concerns in adult LDLT 
donors and recipients [11-15]. In our study, 
biliary and respiratory complications were the 
most common type of donor morbidity, occur-
ring in nearly 13% and 10% of cases, respec-
tively. Incisional hernia only occurred in one 
(3%)  donor.  Brachial  plexus  injury  resulting 
in neuropraxia was also relatively common in 
A2ALL study and resulted in lasting neuro-
muscular disability in two donors [11]. This 
injury usually results from malpositioning on 
the operating table during a prolonged proce-
dure. In fact, the mean operative time was 455 
min for those without neuropraxia and 530 
min  for  those  with  neuropraxia  (p=0.056). 
This  can  result  in  major  functional  disabil-
ity, as well as permanent work disability for 
donors whose occupations depend on motor 
function of the arm. Fortunately, we did not 
observe this complication in our donors. Our 
policy is to always tuck the right arm and have 
the left arm only 80 degree extended.
Middleton and collegues [16] did a systematic 
review of literature on the outcome of LDLT. 
Donor morbidities ranged from 0% to 100%, 
with a median of 16.1%. Biliary complications 
and infections were the most commonly re-
ported morbidities. The median reported rate 
of biliary complications, the most common of 
which were biliary leaks and biliary strictures, 
was 6.2%, with reported rates ranging from 
0% to 38.6%. Rates of infections, most com-
monly  wound  infections,  as  well  as  urinary 
tract infections, pneumonia, and other infec-
tions ranged between 0% and 28.6%. The me-
dian reported infection rate was 5.8%. 
The  Hong  Kong  group  [17,18] reported  an 
overall  major  complication  rate  of  14%  that 
was reduced to 6% in their second 50 patients. 
Minor complications decreased from 26% to 
8%. In our study, the overall complication rate, 
readmissions and grade III complications de-
creased with experience over time (Tables 3 
and 4). We believe that partial hepatectomy 
in living donors has a learning curve which 
appears to approximate about 15 cases. This 
learning  curve  is  not  restricted  to  the  sur-
geons performing the procedure but involves 
all areas of pre- , peri- and post-operative pa-
tient  care.  Our  experience  emphasizes  that 
LDLT can be safely provided by active liver 
transplant programs performing only modest 
number of LDLT. We have been upholding the 
policy that donors deserve treatment of the 
highest standard. We attempted to make the 
process as safe as possible by constant upgrad-
ing the standards of the pre-operative, opera-
tive and post-operative care. The standards, as 
mentioned previously, could be due to many 
factors attributed to patients, surgeons, anes-
thesiologists, nurses, and supporting staff.
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